Back to blog

Back to blog

Back to blog

Why Physicians Are Walking Away from PE Backed Groups

Why Physicians Are Walking Away from PE Backed Groups

Why Physicians Are Walking Away from PE Backed Groups

Date

Date:

March 2, 2026

March 2, 2026

March 2, 2026

Time to read

Time to read

Time to read:

5 mins

5 mins

5 mins

The offer always sounds the same. Above market valuation, a management team to take over the operational side, and a contract that promises you keep full clinical autonomy. After 20 years of running a solo ophthalmology practice, handling billing, HR, equipment and lease negotiations on top of a full surgical schedule, someone finally shows up and says they'll carry the weight for you. So you sign and for about 90 days, it actually works, but then the changes start…

What Autonomy Actually Means in a PE Contract

The word autonomy appears in nearly every physician services agreement attached to a PE acquisition. It's there because the lawyers know you need to see it, but the definition of autonomy in a PE contract and definition of autonomy in your clinical practice are not the same thing.


In a PE agreement, autonomy means you choose the procedure and decide whether to recommend LASIK or PRK. You write the prescription. What it doesn’t cover is how many patients move through your schedule in a day, how long a consultation lasts, which diagnostic equipment stays when the platform standardizes across locations, or what happens when the operations team shortens your informed consent workflow from a 20 minute conversation to three verbal sentences and a 12-page form the patient signs without reading.


And even though you're still the doctor, you just no longer get to decide what being the doctor looks like inside your own practice.

The Non-Compete Problem

The Non-Compete Problem

Every physician employment agreement has some version of a non-compete, and in a traditional practice sale the terms are straightforward. You agree not to practice within a defined radius of the practice you sold, for a defined period after you leave. Both sides know exactly what they're agreeing to before anyone signs.


What PE backed groups have been writing into these clauses over the last five years is different. The restriction applies to "current and future locations" of the platform, which means the non-compete radius expands every time the group acquires another practice. A physician signs a contract covering Manhattan and by the time they want to leave, the group has locations across three boroughs, Long Island, Westchester, and southern Connecticut. The non-compete now covers a region the physician never agreed to, but the language they signed allowed it


We've spoken with physicians who left PE backed groups and had to relocate out of state because the non-compete made it impossible to practice anywhere within driving distance of their own patients.

Volume Pressure and What Gets Lost

The economics of a PE backed ophthalmology platform run on volume. The group paid a premium to acquire your practice and financed that acquisition with debt that needs servicing, and the way they service that debt is by pushing more patients through every practice in the portfolio. And instead of getting a memo about this, you get scheduling changes, an extra two patients per half day block, a 15-minute consultation window where you used to have 25 and a tech who preps the diagnostic results before you walk in so you can "review and confirm" instead of running the workup yourself.


The research confirms what physicians already feel. A study published in the American Journal of Ophthalmology found that PE ownership is associated with shorter appointments, fewer Medicare and Medicaid patients seen, and an 11% mean increase in charges per medical claim compared to independent practices. A separate study reported in Medical Economics found that physician turnover at PE acquired ophthalmology practices increased by 265% compared to baseline rates. These are peer-reviewed findings based on years of Medicare claims data.


For an ophthalmologist, this is where it breaks. Whether your patients are making an elective decision about LASIK or ICL, or managing a chronic condition that requires ongoing intravitreal injections for macular degeneration or careful glaucoma monitoring, the consultation is where trust gets built. The nervous 30 year old sitting in your chair asking about refractive surgery and the 70 year old trying to understand why they need another injection both need the same thing: time, clarity, and a physician who isn't watching a clock set by someone who's never been in the room. When the platform compresses that conversation into a workflow, the surgeon who spent 20 years building a reputation for thoroughness ends up running a volume line. Patients notice, reviews change, referrals slow, and the platform blames the market instead of the schedule it created.

Many transitions require a successor physician concept to ensure continuity of care, maintain payer participation, and support clinical leadership, especially when a founder is stepping back.

This role is often misunderstood as meaning one physician must personally carry every operational burden, but this is not the case.

A clearer way to think about it is this: the successor physician role supports clinical continuity and leadership while the MSO supports operations. This structure connects the two while keeping clinical independence intact.

What Happens When You Push Back

What Happens When You Push Back

Some physicians push back. They tell the operations team the schedule is too compressed, refuse to shorten consultations and flag patient safety concerns about the consent process. What they learn is that dissent inside a PE backed group is a managed process. The first conversation is supportive, the second is documented, and by the third or fourth the physician is being "counseled" on "alignment with practice standards." The subtext is always the same: conform or be managed out.


The ones who leave voluntarily tend to do so quietly, because their contract includes a non-disparagement clause. They can't tell colleagues what happened, and can't warn the next surgeon who gets recruited by the same platform. The silence is a contract term. And it's one reason the data is so striking when it does surface: a 2024 study found that 78% of ophthalmology trainees said they would not even consider employment at a PE-owned practice, citing fear of lost autonomy and reduced quality of patient care.

What the Alternative Looks Like

What the Alternative Looks Like

The structural answer to this problem already exists. A physician owned PC with an MSO providing operational support through a management services agreement where the physician owns the clinical entity, the management company runs operations, and the MSA defines what each side does, pays, and happens if either side wants to walk away.


The difference from a PE deal comes down to four things. Ownership stays with the physician, meaning their name is on the clinical entity, their license governs clinical decisions, and their vote controls what happens inside the practice. The non-compete is geographic and fixed, covering the actual practice location, a defined radius, and a time period, and it doesn't expand when the management company acquires a practice in another zip code. 


The exit is defined before the relationship starts. Both sides agree to the termination provisions upfront, with no rolling extensions and no breakup penalties designed to make leaving more expensive than staying. The consent process stays with the physician too, for example how long a consultation takes, how you explain the risks, how you talk to a patient sitting in your chair for the first time. In an MSO structure, those decisions never leave the exam room.

The Pattern

The Pattern

We didn't set out to write an anti-PE position paper. This is what we heard, repeatedly, from ophthalmologists across New York, New Jersey, and Connecticut who lived through it. The details change from one physician to the next but the structure underneath is always the same. 


A physician joins because the offer sounds like support, and over time that support becomes oversight, the oversight becomes production pressure, and eventually the physician faces a choice between compliance and leaving. 


The contract is designed to make leaving as painful as possible. And every physician we've spoken with who got through it and rebuilt on the other side said the same thing: they wish someone had shown them the structural alternative before they signed.

Why We Built What We Built

Why We Built What We Built

That's why Verdira exists. Practice ownership shouldn't require choosing between doing it alone and giving it up. There's a model where the physician keeps the practice, the clinical authority, and gets operational support without surrendering either one. We're not a PE fund and don't flip practices, load debt onto a physician's balance sheet, or compress consult schedules to service someone else's interest payments.


We're a management company built to acquire and operate ophthalmology practices alongside the physicians who run them, with an agreement that spells out every term before either party commits.


If you've been through the PE experience, or you're being recruited by a group right now and something about the contract doesn't sit right, the structure we're describing is how physician owned practices were always supposed to work.


Verdira Holdings is a healthcare acquisition platform focused on ophthalmology practices. Physician ownership. Transparent structure. No volume quotas. If you're looking for a different model, or you know a colleague who is: verdira.com




As final documents circulate, it is common for physicians to spend more time reviewing details and asking questions. This stage often brings a sharper focus on edge cases, responsibility allocation, and how specific provisions work in practice. Legal review can feel slower and more cumbersome at this point, not because the structure has changed, but because the transaction is moving from concept to execution.
 

That shift naturally increases attention to wording, definitions, and how agreements interact with one another and it’s also normal for physicians to revisit topics that were previously discussed earlier in the process. This does not necessarily mean new risk has emerged.


Operational improvements can also come into sharper focus at this stage. In a well-structured model, any upgrades (including facilities, technology, or equipment changes) should be staged, scoped, and documented, and should not create open-ended spending obligations for the physician practice. 

In most cases, it reflects final diligence and a desire to confirm that roles, obligations, and protections are clearly documented. The most productive approach at this stage is to separate substantive legal or clinical issues from timing pressure and process noise. True risk questions belong with qualified New York healthcare counsel and should be addressed through the documents themselves. 

Process friction is typically resolved through clear sequencing, explanations, and allowing counsel to work through remaining technical points. Clarity at signing tends to reduce downstream friction. Well-structured transactions feel uneventful at close because expectations, responsibilities, and governance have already been made explicit in writing.



We’re here to ensure your hard work is valued and your business thrives as part of Verdira.

Ready to secure your legacy?

We’re here to ensure your hard work is valued and your business thrives as part of Verdira.

Ready to secure your legacy?

Practice may require being listed as an additional insured where appropriate.

MENU